The Biotechnology Innovation Organization (BIO) recently partnered with the National Science Foundation (NSF) to include Small Business Innovation Research (SBIR) at BIO’s 13th Annual World Congress on Industrial Biotechnology.
The conference will feature early-stage industrial biotechnology companies that received funds from the SBIR.
“BIO and NSF have established a great public-private partnership, which first debuted at the 2013 BIO Investor Forum and will now be showcased at the 2016 BIO World Congress on Industrial Biotechnology,” Brent Erickson, executive vice president for BIO’s industrial and environmental section, said. “Through the SBIR grant program, qualified companies can move forward and bring innovative technologies to market. I hope everyone at the World Congress will take the time to stop by and learn about these exciting companies.”
In addition, the conference provides attendees with a networking opportunity.
“The BIO World Congress on Industrial Biotechnology is an excellent opportunity for these companies to showcase their cutting-edge technologies, form long-term partnerships and begin to raise funds in the private sector,” Jesus Soriano, program director for NSF's SBIR/STTR program, said. “NSF’s SBIR/STTR Program shows the government and private sectors working together toward the common goals of spurring job growth, building a bioeconomy and reducing the costs and environmental footprint of manufacturing.”
The conference is scheduled for April 17-20 at the San Diego Convention Center in California.